Korro Bio, Inc.

KRRO·NasdaqCM·Healthcare

Compare

16.62+0.76 (+4.79%)today

At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Key statistics

Previous close15.86

Open15.93

Day range15.9317.00

52-week range5.2036.79

Off day high−2.21%

Off 52-week high−54.82%

Volume263.58K

Avg. volume (3M)169.23K

Market cap244.74M

EPS (TTM)-9.88

Forward P/E-3.76

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)2.36

Shares outstanding14.73M

Short interest13.18% of float

Earnings dateAug 6, 2026 (est.)

Analyst target20.20

Profit margin0.00%

Against its peers

Compare in full ›

	KRRO	PRQR	KURA	BBOT	SCTX	KYNB
Market cap	244.74M	198.98M	676.99M	184.40M	317.67M	16.03M
P/E (TTM)	—	—	—	—	—	—
Forward P/E	-3.8	-3.0	-3.2	-0.8	-4.6	-0.3
Price/book	2.4	2.2	14.0	0.6	-0.3	-0.5
Dividend yield	—	—	—	—	—	—
1-year change	−50.97%	−42.44%	−25.10%	−81.29%	−11.54%	−64.00%
Today	+4.79%	+2.92%	−22.98%	−0.86%	+3.58%	−8.12%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Korro Bio's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
ProQR Therapeutics N.V.PRQR · Biotechnology	198.98M	1.4100	+2.92%
Kura Oncology, Inc.KURA · Biotechnology	676.99M	7.61	−22.98%
BridgeBio Oncology Therapeutics, Inc.BBOT · Biotechnology	184.40M	2.3000	−0.86%
Scribe Therapeutics Inc.SCTX · Biotechnology	317.67M	16.78	+3.58%
Kyntra Bio, Inc.KYNB · Biotechnology	16.03M	3.9600	−8.12%
Precision BioSciences, Inc.DTIL · Biotechnology	226.84M	8.12	+16.50%
Solid Biosciences Inc.SLDB · Biotechnology	699.11M	6.52	+3.82%
Keros Therapeutics, Inc.KROS · Biotechnology	214.73M	10.83	0.00%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
Transgene SATNG.PA · Illkirch-Graffenstaden, France	214.81M	0.7720	+1.85%
Protalix BioTherapeutics, Inc.PLX · Hackensack, NJ	216.74M	2.6900	+3.07%
Bright Minds Biosciences Inc.DRUG · New York, NY	187.02M	18.96	−12.02%
Sol-Gel Technologies Ltd.SLGL · Ness Ziona, Israel	216.08M	66.00	+3.43%
Eledon Pharmaceuticals, Inc.ELDN · Irvine, CA	219.41M	2.7000	+3.05%
Palisade Bio, Inc.PALI · Denver, CO	217.84M	1.2500	+1.63%
Keros Therapeutics, Inc.KROS · Lexington, MA	214.73M	10.83	0.00%
Newron Pharmaceuticals S.p.A.NP5.F · Bresso, MI	205.50M	10.05	−0.50%

Healthcare companies of a similar market value (233.55M).

Company	Mkt cap	Price	Today
Transgene SATNG.PA · Biotechnology	214.81M	0.7720	+1.85%
Protalix BioTherapeutics, Inc.PLX · Biotechnology	216.74M	2.6900	+3.07%
American Well CorporationAMWL · Health Information Services	210.06M	12.35	−3.06%
Lifecore Biomedical, Inc.LDE.F · Drug Manufacturers - Specialty & Generic	210.38M	5.55	−0.89%
Bright Minds Biosciences Inc.DRUG · Biotechnology	187.02M	18.96	−12.02%
Sol-Gel Technologies Ltd.SLGL · Biotechnology	216.08M	66.00	+3.43%
Mayne Pharma Group LimitedMYX.AX · Medical Distribution	221.92M	2.7100	+3.44%
Eledon Pharmaceuticals, Inc.ELDN · Biotechnology	219.41M	2.7000	+3.05%

Also based in Cambridge, Massachusetts, then elsewhere in Massachusetts.

Company	Mkt cap	Price	Today
Moderna, Inc.MRNA · Cambridge, MA Odds	103.15B	258.38	+13.11%
Biogen Inc.BIIB · Cambridge, MA	37.61B	254.46	+2.22%
Akamai Technologies, Inc.AKAM · Cambridge, MA Odds	12.35B	85.93	−0.69%
GE Vernova Inc.GEV · Cambridge, MA	220.43B	832.83	−9.30%
Alnylam Pharmaceuticals, Inc.ALNY · Cambridge, MA Odds	21.57B	161.08	+0.74%
HubSpot, Inc.HUBS · Cambridge, MA	11.09B	216.64	−4.21%
Nuvalent IncNUVL · Cambridge, MA	9.81B	123.96	0.00%
Scholar Rock Holding CorporationSRRK · Cambridge, MA	5.61B	46.09	+4.80%

Companies that serve the same markets: life sciences.

Company	Mkt cap	Price	Today
Enanta Pharmaceuticals, Inc.9EP.F · life sciences	266.50M	9.15	−2.66%
Nxera Pharma Co., Ltd.4565.T · life sciences	158.60B	1,729.00	+13.75%
Celltrion, Inc.068270.KS · life sciences	49.02T	215,000.00	+7.50%
Bio-Techne CorporationTE1.F · life sciences	9.93B	63.22	−0.97%
Zealand Pharma A/S0NZU.IL · life sciences	14.45B	242.30	+1.66%
Genovis AB (publ.)GENO.ST · life sciences	1.47B	21.85	+3.31%
Dr. Reddy's Laboratories LimitedRDDA.F · life sciences	10.75B	12.90	+2.38%
Joinn Laboratories(China)Co.,Ltd.603127.SS · life sciences	34.88B	46.55	+5.56%

The stocks whose daily moves over the past year went most closely with Korro Bio's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
Solid Biosciences Inc.SLDB · Correlation 0.39	699.11M	6.52	+3.82%
Keros Therapeutics, Inc.KROS · Correlation 0.38	214.73M	10.83	0.00%
Beam Therapeutics Inc.BEAM · Correlation 0.33	2.88B	27.79	+5.55%
Kura Oncology, Inc.KURA · Correlation 0.32	676.99M	7.61	−22.98%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All KRRO news ›

True North Radio Network·Oct 16

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage Gale Warning until SAT 4:00 AM EDT CAMBRIDGE, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a…

HC Wainwright & Co. reiterates Buy rating on Korro Bio, $15 price target

HC Wainwright & Co. reiterated their Buy rating on Korro Bio's stock with a price target of $15.00. The price target implies an upside of 50.5% from the Oct 5 close of $9.97. Promising Clinical Developments: Korro Bio has initiated its…

CLDX MGTX

From the 4Search news index, newest first.

In the news

3mentions in 30 days

3with it in the headline

Positivesentiment

Most coverage from

stocktitan.net1
tradingview.com1
truenorthradionetwork.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

About

Profile ›

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotroph…

SectorHealthcare

IndustryBiotechnology

Chief executiveRam Aiyar MBA, Ph.D.

Employees57

HeadquartersCambridge, MA, United States

Websitekorrobio.com

Analyst ratings

Analysis ›

Strong buy10 analysts

Strong buy 1
Buy 8
Hold 1
Sell 0
Strong sell 0

12-month price target20.20+21.54%

Low 10.00Current 16.62High 30.00

Wall Street analyst consensus. Not a recommendation.

Earnings

Reported EPS
Estimate

Next report: Thu, Aug 6, 2026 (estimated)

Quarterly results

Financials ›

Revenue
Net income

Financial statements from company filings with the U.S. SEC (EDGAR XBRL).

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Most widely held	0	0	—
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance